Investing.com - Needham maintained its Hold rating on Teleflex (NYSE:TFX) after the company announced agreements to divest two business segments for approximately $2 billion in combined value.

WAYNE, Pa., Dec. 09, 2025 (GLOBE NEWSWIRE) -- Teleflex Incorporated (NYSE:TFX), a leading global provider of medical technologies, today announced it has entered into definitive agreements to sell the ...

Teleflex (TFX) has agreed to sell its acute care, interventional urology and OEM businesses to two buyers for a combined $2.03 billion in cash, subject to adjustments. Intersurgical will acquire the ...

After announcing plans to split up the company near the top of this year, Teleflex said it has found new homes for its businesses spanning acute care, urology and medical hardware manufacturing. Two ...

Teleflex is selling its acute care, interventional urology, and original equipment manufacturer (OEM) businesses in two separate deals totalling over $2bn as part of the company’s broader portfolio ...

Private equity firms Montagu and Kohlberg have announced plans to acquire Wayne, PA-based OEM Teleflex Medical for $1.5 billion in a carve-out transaction. Teleflex Medical OEM, which has been in ...

Teleflex Medical OEM has seven state-of-the-art facilities across the US, Mexico, and Ireland Greg Stotts, who joined Teleflex in 2006 and currently serves as Teleflex Medical OEM’s president and ...

Dec 9 (Reuters) - Medical device maker Teleflex (TFX.N), opens new tab said on Tuesday it would sell three units for a combined $2.03 billion, as it sharpens its focus on its critical care and ...

To continue reading this content, please enable JavaScript in your browser settings and refresh this page. Preview this article 1 min Founded in 1943, the company has ...

NEW YORK, December 09, 2025--(BUSINESS WIRE)--Montagu and Kohlberg, two leading middle-market private equity firms, today announced that they have entered into a definitive agreement to acquire ...

(RTTNews) - Teleflex Inc. (TFX), a global provider of medical technologies, has entered into definitive agreements to divest its Acute Care, Interventional Urology, and OEM businesses for a combined ...